Can We Ensure the Safe Use of Known Human Teratogens?: Introduction of Generic Isotretinoin in the US as an Example

Author： Margaret A. Honein   Cynthia A. Moore   J. David Erickson  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.14, 2004-01, pp. : 1069-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can We Ensure the Safe Use of Known Human Teratogens?: The iPLEDGE™ Test Case

By Honein Margaret A.  

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 5-15

Adis International

Access to resources Recommend Favorite

Isotretinoin prescribing for acne SMART in the US?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 490, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Isotretinoin prescribing for acne SMART in the US?

By  

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Do Nanomedicines Require Novel Safety Assessments to Ensure their Safety for Long-Term Human Use?

By Hoet Peter   Legiest Barbara   Geys Jorina   Nemery Benoit  

Drug Safety, Vol. 32, Iss. 8, 2009-08 ,pp. : 625-636

Adis International

Access to resources Recommend Favorite

Dextromethorphan safe for use in pregnancy?

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite